Acadian Timber (ADN) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
25 Nov, 2025Opening remarks and agenda
Meeting commenced at 11:00 A.M. Eastern Time, chaired by the Chairman with all directors and key executives present.
Virtual meeting platform enabled broad shareholder participation and access.
Secretary and Scrutineer appointed; voting procedures and eligibility clarified.
Quorum confirmed, and the meeting was declared properly constituted.
Board and executive committee updates
Six directors nominated and elected to serve until the next AGM, with minimal votes withheld.
PricewaterhouseCoopers LLP reappointed as auditors with board authorized to fix remuneration.
Financial performance review
2024 sales reached $116.2 million, up from $93.5 million in 2023, with $24.6 million from carbon credit sales.
Adjusted EBITDA for 2024 was $38.9 million (33% margin), up from $20.6 million (22% margin) in 2023.
Free cash flow per share rose to $1.69 in 2024 from $0.88 in 2023; net liquidity at year-end was $29.3 million.
Q1 2025 sales were $24.8 million, with no carbon credit sales; adjusted EBITDA was $4.7 million.
Q1 2025 net income was $3.7 million, or $0.21 per share.
Latest events from Acadian Timber
- Q4 sales and net income rose, but full-year results were weighed by lower carbon credit sales.ADN
Q4 202512 Feb 2026 - Record Q2 driven by carbon credit sales, strong cash flow, and improved liquidity.ADN
Q2 20242 Feb 2026 - Lower Q3 earnings as timber prices fell, but carbon and real estate projects advance.ADN
Q3 202417 Jan 2026 - 2024 sales surged on carbon credits, but net income declined as market headwinds persisted.ADN
Q4 202417 Dec 2025 - Lower Q1 revenue and profit driven by no carbon credit sales; Maine logging shift to cut costs.ADN
Q1 202525 Nov 2025 - Lower Q2 sales and earnings driven by Maine challenges and no carbon credit sales; ramp-up underway.ADN
Q2 202524 Nov 2025 - Sales fell but net income rose; Maine transition and carbon credit delays shaped results.ADN
Q3 202513 Nov 2025